关注
Dr. Parul Grover
Dr. Parul Grover
Associate Professor, KIET School of Pharmacy
在 kiet.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A comprehensive review on Nyctanthes arbortristis
B Gulshan, KA Suri, G Parul
Int J Drug Dev Res 7 (1), 183-193, 2015
452015
Synthesis, anticonvulsant activity and comparative QSAR study of some novel 1, 2, 5-trisubstituted benzimidazole derivatives
J Singh, P Grover, DP Pathak
Acta Pharmaceutica Sciencia 52 (4), 2010
322010
LC and LC–MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway
L Mehta, T Naved, P Grover, M Bhardwaj, D Mukherjee
Journal of Pharmaceutical and Biomedical Analysis 194, 113768, 2021
312021
Current strategies and novel drug approaches for Alzheimer disease
R Ghai, K Nagarajan, M Arora, P Grover, N Ali, G Kapoor
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2020
312020
Hypoglycemic herbs and their polyherbal formulations: a comprehensive review
D Katiyar, V Singh, SJ Gilani, R Goel, P Grover, A Vats
Medicinal Chemistry Research 24 (1), 1-21, 2015
252015
Identification, isolation, and structural characterization of novel forced degradation products of Darunavir using advanced analytical techniques like UPLC–MS, prep-HPLC, HRMS …
AK Modini, M Ranga, U Puppala, M Kaliyapermal, MKR Geereddy, ...
Chromatographia 86 (1), 63-78, 2023
152023
Current developments in the pyran-based analogues as anticancer agents
P Grover, M Bhardwaj, L Mehta, G Kapoor, PA Chawla
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022
152022
LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway
P Grover, M Bhardwaj, L Mehta
Journal of Pharmaceutical and Biomedical Analysis 206, 114351, 2021
142021
Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF-MS/MS and in silico toxicity prediction
L Mehta, T Naved, P Grover, M Bhardwaj, D Mukherjee, DR Vennapu
Journal of Liquid Chromatography & Related Technologies 44 (5-6), 285-297, 2021
142021
Exploring the multitarget potential of iridoids: advances and applications
P Grover, L Mehta, A Malhotra, G Kapoor, K Nagarajan, P Kumar, ...
Current Topics in Medicinal Chemistry 23 (5), 371-388, 2023
132023
Recent Advances in N‐Hyrdoxypthalimide: As a Free Radical Initiator and its Applications
M Bhardwaj, P Grover, B Rasool, D Mukherjee
Asian Journal of Organic Chemistry 11 (11), e202200442, 2022
132022
Different aspects of polymers–A review article
S Bhatt, A Pathak, P Grover, A Bharadwaj, D Bhatia, R Tomar, M Kaurav
Materials Today: Proceedings 64, 1490-1495, 2022
122022
Development and validation of novel and highly sensitive stability-indicating reverse phase ultra performance liquid chromatography method for quantification of Ibrutinib and …
L Mehta, T Naved, P Grover, M Bhardwaj, D Mukherjee
Indian Journal of Pharmaceutical Sciences 82 (6), 958-966, 2020
122020
Analytical method development and validation for assay of rufinamide drug
J Singh, S Sangwan, P Grover, L Mehta, D Kiran, A Goyal
Journal of Pharmaceutical Technology, Research and Management 1 (2), 191-203, 2013
122013
Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid chromatography-quadrupole-time of …
P Grover, M Bhardwaj, D Mukherjee
Journal of Pharmaceutical and Biomedical Analysis 221, 115045, 2022
112022
Current Advancement in the Oxadiazole-Based Scaffolds as Anticancer Agents
G Kapoor, R Bhutani, DP Pathak, G Chauhan, R Kant, P Grover, ...
Polycyclic Aromatic Compounds 42 (7), 4183-4215, 2022
112022
Advances on quinazoline based congeners for anticancer potential
P Grover, M Bhardwaj, G Kapoor, L Mehta, R Ghai, K Nagarajan
Current Organic Chemistry 25 (6), 695-723, 2021
92021
Development and validation of novel and highly sensitive stability-indicating reverse phase UPLC method for quantification of Dabrafenib and its ten degradation products
P Grover, M Bhardwaj, L Mehta, T Naved, V Handa
Indian Journal of Pharmaceutical Education and Research 56 (3), 888-98, 2022
82022
Identification of Potent Bioassay Guided Terpenoid and Glycoside Root Fractions of Astragalus candolleanus against Clinically Significant Bacterial Strains
K Nagarajan, R Ghai, G Varshney, P Grover, C Genovese, F D’Angeli, ...
International Journal of Microbiology 2022 (1), 4584799, 2022
82022
Metabolite detection and profiling using analytical methods
L Mehta, P Grover, T Naved, D Mukherjee
Current Pharmaceutical Analysis 17 (1), 2-9, 2021
82021
系统目前无法执行此操作,请稍后再试。
文章 1–20